Ketorolac trometamol (Tora-dol)
Ketorolac trometamol
Ascendis Pharma (Pty) Ltd
Registration
- Applicant
- Ascendis Pharma (Pty) Ltd
- Registrations
- 3
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Tora-dol 1 % EACH 1 ml CONTAINS KETOROLAC TROMETAMOL 10 mg | 1 % | 28057028/2.7/0570 | Registered | Not determined | None |
| Tora-dol 3 % EACH 1 ml CONTAINS KETOROLAC TROMETAMOL 30 mg | 3 % | 28057128/2.7/0571 | Registered | Not determined | None |
| Tora-dol EACH TABLET CONTAINS KETOROLAC TROMETAMOL 10 mg | Not listed | 28057228/2.7/0572 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Ketorolac
- except when intended for ophthalmic use.
Consolidated Schedules 06 July 2026, line 6848
S4: Trometamol
Consolidated Schedules 06 July 2026, line 8299
S3: Ketorolac
- when intended for ophthalmic use.
Consolidated Schedules 06 July 2026, line 3860
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
This product's active ingredient could not be matched to a single known compound.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.